Jaime Jankelevich, Licenciate in Biochemistry; Biochemist; DPL Finance. President and Founder of Etika Consultores in 1988, Company dedicated to Consultancy to the Pharmaceutical Industry in Latin America. I was born in Santiago, Chile, March19th, 1949. I am married and we have two sons. My career started as a researcher in Biochemistry at the University of Chile to later move into the pharmaceutical industry as Marketing Manager of a major company in Chile. After 8 years in the industry, I left to I establish Etika Consultores. My interest in technology led me to develop a software specialized in market analysis of the Pharma Industry. It's currently distributed all along Latin America and in Spain. I play golf, practice skiing and love music (classical, jazz, opera) and reading non fiction
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
The enormous advancement in the biological sciences that is taking place has begun to change the traditional way of practicing medicine. Far-reaching biological products are being approved and news about breakthroughs are occupying the media headlines. However, selecting the biotechnology firms for investment requires not only an understanding of the company's finances, but also deep knowledge of the company's potential and the potential and scientific validity of it's products and technologies.
Our Mission is evaluating biotechnology companies, their products, their technologies, scientists, managements, as well as their finances. Our goal is to impart our readers with the knowledge and insight so that they may have a heightened understanding and appreciation for the biotechnology industry.
The Prohost Letter has been in circulation since 1992. Our readers are comprised of venture capital, fund managers, investors, medical professionals and individuals with one common interest, biotechnology.
Prohost Letter is posted in the members areas on the www.prohostbiotech.com. around 40 times a year. Articles are posted several times a week for subscribers in TODAY'S HIGHLIGHTS section and in News & Comments sector for all website visitors
Progenitor of PC virtualization (now a multi-billion dollar cloud-related industry), serial startup entrepreneur, trend-caster and visionary at the intersection of biz & tech (http://www.trendcaller.com), contributor for SeekingAlpha and VentureBeat, author of the book "The Crowdfunding Revolution | Social Networking Meets Venture Financing", founding team member in a microprocessor startup, author and lead for two Open Source projects, public speaker, prolific idea creator, author of multiple patents, and news and business book junkie. I have a degree in computer science and started my career at MIT Lincoln Laboratory in space-based radar and satellite communication. I'll also be giving a keynote at the Smeal College of Business (Penn State U) conference this Fall 2010, related to Impact through Networks.